hDcp1b inhibitors belong to a specialized chemical class designed to selectively target and modulate the activity of the human Decapping protein 1b (hDcp1b). As an essential component of the mRNA decay machinery, hDcp1b plays a crucial role in post-transcriptional gene regulation by facilitating the removal of the 5' cap structure from mRNAs, marking them for degradation. The inhibitors developed for hDcp1b are intricately designed to interact with the unique structural features of this protein, aiming to disrupt its normal interactions within the cellular environment and potentially influence various aspects of mRNA decay.
The molecular architecture of hDcp1b inhibitors is precisely tailored to engage specific binding sites on the protein, inducing changes in its conformation and dynamics. In laboratory research, these inhibitors serve as crucial tools, enabling scientists to investigate the nuanced functions of hDcp1b in various cellular contexts. By selectively inhibiting hDcp1b, researchers aim to unravel the complex mechanisms of mRNA decay, contributing to a deeper understanding of the intricate network of molecular players involved in the regulation of gene expression. The study of hDcp1b inhibitors stands at the forefront of advancing our comprehension of post-transcriptional gene regulation and the potential implications of manipulating mRNA decay processes.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
Binds to DNA and inhibits RNA polymerase, potentially decreasing hDcp1b transcription. | ||||||
α-Amanitin | 23109-05-9 | sc-202440 sc-202440A | 1 mg 5 mg | $269.00 $1050.00 | 26 | |
Inhibits RNA polymerase II, potentially reducing mRNA synthesis including that of hDcp1b. | ||||||
DRB | 53-85-0 | sc-200581 sc-200581A sc-200581B sc-200581C | 10 mg 50 mg 100 mg 250 mg | $43.00 $189.00 $316.00 $663.00 | 6 | |
Inhibits transcription elongation by RNA polymerase II, could reduce hDcp1b mRNA levels. | ||||||
Triptolide | 38748-32-2 | sc-200122 sc-200122A | 1 mg 5 mg | $90.00 $204.00 | 13 | |
Known to inhibit the transcription of various genes, could potentially suppress hDcp1b expression. | ||||||
Cordycepin | 73-03-0 | sc-203902 | 10 mg | $101.00 | 5 | |
Inhibits RNA polyadenylation, potentially reducing the stability of hDcp1b mRNA. | ||||||
Flavopiridol | 146426-40-6 | sc-202157 sc-202157A | 5 mg 25 mg | $78.00 $259.00 | 41 | |
Inhibits cyclin-dependent kinases (CDKs) involved in transcription, may affect hDcp1b expression. | ||||||
Leptomycin B | 87081-35-4 | sc-358688 sc-358688A sc-358688B | 50 µg 500 µg 2.5 mg | $107.00 $416.00 $1248.00 | 35 | |
Inhibits nuclear export of RNA, potentially affecting mRNA levels of hDcp1b. | ||||||
CX-5461 | 1138549-36-6 | sc-507275 | 5 mg | $245.00 | ||
Inhibits RNA polymerase I, potentially altering cellular transcriptional environment affecting hDcp1b. | ||||||
(±)-JQ1 | 1268524-69-1 | sc-472932 sc-472932A | 5 mg 25 mg | $231.00 $863.00 | 1 | |
Inhibits BET bromodomain proteins, could lead to downregulation of certain transcription programs including hDcp1b. | ||||||
I-BET 151 Hydrochloride | 1300031-49-5 (non HCl Salt) | sc-391115 | 10 mg | $450.00 | 2 | |
BET bromodomain inhibitor that may downregulate genes involved in mRNA processing. | ||||||